Seeking Alpha

3B NEXUS's  Instablog

3B NEXUS
Send Message
Enterprise Online Video Platform & Portal - for Investors, Corporates and Market Specialists & Media. Software-as-a-Service (SaaS) video hosting and streaming solution that helps content owners ingest, transcode, store, manage, protect, publish, syndicate, track and monetize online... More
My company:
3B NEXUS
My blog:
Bulls Bears & Butterflies®
  • Corporate Webcast: Daiichi Sankyo/U3 Pharma: Development Of Innovative Cancer Therapies. 0 comments
    Feb 8, 2012 3:57 PM
    Daiichi Sankyo/U3 Pharma: development of innovative cancer therapies.

    The biotech company U3 Pharma, which belongs to Daiichi Sankyo since 2008, is a source of several new oncology compounds for the Japanese mother company. Most advanced is U3-1287, a anti-HER3 antibody. That could lead to a new cancer drug with high benefits for the patients. With its innovative research and development U3 Pharma contributes to the goal of Daiichi Sankyo to build up a top-ten oncology pipeline till 2015.

    Broadcast live, record and publish your investor, corporate and analyst videos on 3B NEXUS for our targeted distribution. 3bnexus.com

Back To 3B NEXUS's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.